1. Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in vitro and ex vivo Study
- Author
-
Natalia Estrada-Ortiz, Chiara Gabbiani, Angela Casini, Marina H. de Jager, Geny M. M. Groothuis, Federica Guarra, Lorella Marchetti, Inge A. M. de Graaf, Nanomedicine & Drug Targeting, Groningen Research Institute of Pharmacy, Biopharmaceuticals, Discovery, Design and Delivery (BDDD), and Medicinal Chemistry and Bioanalysis (MCB)
- Subjects
Male ,Stereochemistry ,DNA-BINDING ,gold NHC complexes ,Antineoplastic Agents ,010402 general chemistry ,Kidney ,01 natural sciences ,Biochemistry ,MEDICINAL INORGANIC-CHEMISTRY ,CISPLATIN ,chemistry.chemical_compound ,Heterocyclic Compounds ,Cell Line, Tumor ,Neoplasms ,Drug Discovery ,Moiety ,Animals ,Humans ,QD ,General Pharmacology, Toxicology and Pharmaceutics ,Rats, Wistar ,AGENTS ,Cytotoxicity ,BIOLOGICAL-PROPERTIES ,precision-cut kidney slices ,PLATINUM ,SLICES ,Pharmacology ,010405 organic chemistry ,Ligand ,Organic Chemistry ,CANCER ,In vitro ,0104 chemical sciences ,chemistry ,PALLADIUM(II) ,Cell culture ,Cancer cell ,alkynyl compounds ,cytotoxicity ,Molecular Medicine ,GOLD(III) COMPLEXES ,Carbene ,Methane ,Organogold Compounds ,Ex vivo ,organometallics - Abstract
A series of organometallic AuI N-heterocyclic carbene (NHC) complexes was synthesized and characterized for anticancer activity in four human cancer cell lines. The compounds' toxicity in healthy tissue was determined using precision-cut kidney slices (PCKS) as a tool to determine the potential selectivity of the gold complexes ex vivo. All evaluated compounds presented cytotoxic activity toward the cancer cells in the nano-or low micromolar range. The mixed AuI NHC complex, (tert-butylethynyl)-1,3-bis-(2,6-diisopropylphenyl) imidazol-2-ylidene gold(I), bearing an alkynyl moiety as ancillary ligand, showed high cytotoxicity in cancer cells in vitro, while being barely toxic in healthy rat kidney tissues. The obtained results open new perspectives toward the design of mixed NHC-alkynyl gold complexes for cancer therapy.
- Published
- 2017